Lipoprotein (a): a genetic marker for cardiovascular disease and target for emerging therapies

A Cesaro, A Schiavo, E Moscarella… - Journal of …, 2021 - journals.lww.com
Abstract Lipoprotein (a)[Lp (a)] is an established cardiovascular risk factor, and growing
evidence indicates its causal association with atherosclerotic disease because of the …
被引用次数：57 相关文章

[引用][C] Lipoprotein (a): a genetic marker for cardiovascular disease and target for emerging therapies

A Cesaro, A Schiavo, E Moscarella, S Coletta… - Journal of …, 2020 - cir.nii.ac.jp

Lipoprotein (a): a genetic marker for cardiovascular disease and target for emerging therapies

A Cesaro, A Schiavo, E Moscarella… - JOURNAL OF …, 2021 - iris.unicampania.it
Abstract Lipoprotein (a)[Lp (a)] is an established cardiovascular risk factor, and growing
evidence indicates its causal association with atherosclerotic disease because of the …

Lipoprotein (a): a genetic marker for cardiovascular disease and target for emerging therapies

A Cesaro, A Schiavo, E Moscarella… - JOURNAL OF …, 2020 - iris.uniroma1.it
Abstract Lipoprotein (a)[Lp (a)] is an established cardiovascular risk factor, and growing
evidence indicates its causal association with atherosclerotic disease because of the …

Lipoprotein (a): a genetic marker for cardiovascular disease and target for emerging therapies

A Cesaro, A Schiavo, E Moscarella… - Journal of …, 2021 - pubmed.ncbi.nlm.nih.gov
Lipoprotein (a)[Lp (a)] is an established cardiovascular risk factor, and growing evidence
indicates its causal association with atherosclerotic disease because of the proatherogenic …

Lipoprotein (a): a genetic marker for cardiovascular disease and target for emerging therapies.

A Cesaro, A Schiavo, E Moscarella… - Journal of …, 2021 - europepmc.org
Lipoprotein (a)[Lp (a)] is an established cardiovascular risk factor, and growing evidence
indicates its causal association with atherosclerotic disease because of the proatherogenic …